Myriad Genetics, Inc. (MYGN)
3.995
-0.02
(-0.62%)
USD |
NASDAQ |
Sep 23, 16:00
3.995
0.00 (0.00%)
After-Hours: 20:00
Myriad Genetics Price to Book Value : 1.257 for Sept. 23, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 22, 2026 | 1.265 |
| September 21, 2026 | 1.262 |
| September 18, 2026 | 1.224 |
| September 17, 2026 | 1.302 |
| September 16, 2026 | 1.214 |
| September 15, 2026 | 1.221 |
| September 14, 2026 | 1.192 |
| September 11, 2026 | 1.076 |
| September 10, 2026 | 1.057 |
| September 09, 2026 | 1.004 |
| September 08, 2026 | 1.000 |
| September 04, 2026 | 1.004 |
| September 03, 2026 | 1.016 |
| September 02, 2026 | 1.016 |
| September 01, 2026 | 1.000 |
| August 31, 2026 | 1.013 |
| August 28, 2026 | 0.9941 |
| August 27, 2026 | 1.000 |
| August 26, 2026 | 0.9815 |
| August 25, 2026 | 1.004 |
| August 24, 2026 | 0.9595 |
| August 21, 2026 | 1.007 |
| August 20, 2026 | 1.013 |
| August 19, 2026 | 1.004 |
| August 18, 2026 | 0.9028 |
| Date | Value |
|---|---|
| August 17, 2026 | 0.9595 |
| August 14, 2026 | 0.9532 |
| August 13, 2026 | 0.9972 |
| August 12, 2026 | 1.016 |
| August 11, 2026 | 1.013 |
| August 10, 2026 | 1.022 |
| August 07, 2026 | 1.026 |
| August 06, 2026 | 1.000 |
| August 05, 2026 | 0.9909 |
| August 04, 2026 | 0.9972 |
| August 03, 2026 | 0.95 |
| July 31, 2026 | 0.8997 |
| July 30, 2026 | 1.689 |
| July 29, 2026 | 1.586 |
| July 28, 2026 | 1.674 |
| July 27, 2026 | 1.714 |
| July 24, 2026 | 1.765 |
| July 23, 2026 | 1.793 |
| July 22, 2026 | 1.780 |
| July 21, 2026 | 1.859 |
| July 20, 2026 | 1.862 |
| July 17, 2026 | 1.944 |
| July 16, 2026 | 1.947 |
| July 15, 2026 | 1.985 |
| July 14, 2026 | 1.90 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Natera, Inc. | 30.80 |
| Sera Prognostics, Inc. | 1.375 |
| BioRestorative Therapies, Inc. | 1.069 |
| CareDx, Inc. | 6.574 |
| Exagen, Inc. | 16.93 |
Price to Book Value Related Metrics
| PS Ratio | 0.4642 |
| Price | 3.995 |
| Earnings Yield | -30.00% |
| Market Cap | 381.92M |